Semi-sitting Versus Supine Position in Endoscopic Skull Base Surgery
PosESS
1 other identifier
interventional
54
1 country
1
Brief Summary
This study is to prospectively compare the standard supine (control group) and the semi-sitting position (head elevation of 30°; intervention group) in endoscopic endonasal pituitary surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 5, 2020
CompletedFirst Posted
Study publicly available on registry
October 14, 2020
CompletedStudy Start
First participant enrolled
January 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 29, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 29, 2024
CompletedApril 29, 2025
April 1, 2025
3.4 years
October 5, 2020
April 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Intraoperative blood loss
Intraoperative blood loss, calculated as follow: volume in the suction bag minus volume of rinsing water in Milliliters (ml). The surgery is divided into four steps: 1. endonasal phase, 2. osteodural exposure. 3. sellar stage and 4. skull base defect closure. For each step, the primary outcome will be assessed.
Intraoperative
Frequency of interruption of the surgical workflow due to disturbing blood or a bleeding in the surgical field (number)
Frequency of interruption of the surgical workflow due to disturbing blood or a bleeding in the surgical field. This will be assessed by an independent blinded neurosurgeon, who will watch the operative video after the surgery.
During surgery
Secondary Outcomes (9)
Change in intraoperative Mean Arterial Pressure (MAP)
Intraoperative
Amount of intravenous fluid administered during surgery (ml)
Intraoperative
Need for vasoactive drugs (vasopressors) (number)
at Day 1 (day of surgery)
Incidence of air embolism (number)
at Day 1 (day of surgery)
Operative time (minutes)
During surgery
- +4 more secondary outcomes
Study Arms (2)
Study Intervention
ACTIVE COMPARATOREndonasal endoscopic pituitary surgery in semi-sitting position
Control Intervention
ACTIVE COMPARATOREndonasal endoscopic pituitary surgery in supine position
Interventions
Patients will be placed in semi-sitting position. To achieve the semi-sitting position, the patient is placed in supine position. The operating table is then separated and flexed to elevate the torso (angle of 30°). The head, which is fixed in a head clamp, is slightly flexed to bring the floor of the sella right in front of the surgeon and gently rotated toward the operating team.
Patients will be operated in the standard supine neutral position
Eligibility Criteria
You may qualify if:
- Patients with a presumed pituitary pathologies who are suitable for endoscopic endonasal surgical resection
You may not qualify if:
- Patients with known hemorrhagic or thrombophilic disorders
- Patients with conditions associated with high central venous pressure: congestive heart failure, pulmonary hypertension, chronic obstructive pulmonary disease (COPD), interstitial lung disease, pregnancy
- Patients with poor cardiopulmonary condition (unable to perform 4 metabolic equivalents without stopping (climb a flight of stairs))
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Neurosurgery, University Hospital Basel
Basel, 4031, Switzerland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jonathan Rychen
Department of Neurosurgery, University Hospital Basel
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 5, 2020
First Posted
October 14, 2020
Study Start
January 22, 2021
Primary Completion
June 29, 2024
Study Completion
June 29, 2024
Last Updated
April 29, 2025
Record last verified: 2025-04